scout
Opinion|Videos|February 28, 2025

CheckMate-9ER: Updates Presented at ASCO 2025

Panelists discuss how the latest progression-free survival, overall survival, and overall response rate data presented at ASCO 2025 demonstrate significant advancements in treatment efficacy across multiple tumor types.

Newsletter

Stay up to date on practice-changing data in community practice.


Latest CME